139 related articles for article (PubMed ID: 2101643)
21. Intact T-cell regenerative capacity in childhood acute lymphoblastic leukemia after remission induction therapy.
Moritz B; Eder J; Meister B; Heitger A
Med Pediatr Oncol; 2001 Feb; 36(2):283-9. PubMed ID: 11452936
[TBL] [Abstract][Full Text] [Related]
22. [DBMP-85 was effective at diagnosis and LVP was effective at relapse in a case of acute mixed leukemia].
Endo M; Kanemaru M; Kubo Y; Kouda K; Sakurai T; Iizuka Y; Takeuchi J; Horikoshi A; Ohshima T
Rinsho Ketsueki; 1990 Mar; 31(3):320-4. PubMed ID: 2366335
[TBL] [Abstract][Full Text] [Related]
23. [Study of reinduction chemotherapy in bone marrow relapse of childhood acute lymphoblastic leukemia].
Sato Y; Ito R; Saito T; Suto Y; Tateoka N; Onodera N; Ikeda Y; Ito E; Miyano T; Tachibana N
Rinsho Ketsueki; 1989 Nov; 30(11):1923-30. PubMed ID: 2607611
[TBL] [Abstract][Full Text] [Related]
24. Immune response of post-transplant peripheral lymphocytes against the patient pre-B cell line, NAGL-1.
Kasai M; Akatsuka Y; Emi N; Taji H; Kohno A; Abe A; Tanimoto M; Kodera Y; Saito H
Int J Hematol; 1999 Feb; 69(2):112-8. PubMed ID: 10071461
[TBL] [Abstract][Full Text] [Related]
25. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
[TBL] [Abstract][Full Text] [Related]
26. Acute promyelocytic leukemia with T-cell markers and particular response to treatment. Report of a case.
Berceanu S; Roman S; Moldoveanu E; Ursea C; Munteanu N
Haematologica; 1989; 74(1):75-9. PubMed ID: 2498188
[TBL] [Abstract][Full Text] [Related]
27. Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical study.
Bassan R; Pogliani E; Lerede T; Fabris P; Rossi G; Morandi S; Casula P; Lambertenghi-Deliliers G; Vespignani M; Izzi T; Coser P; Corneo G; Barbui T
Haematologica; 1999 Dec; 84(12):1088-93. PubMed ID: 10586210
[TBL] [Abstract][Full Text] [Related]
28. Acute lymphoblastic leukaemia with giant intracytoplasmic inclusion--a case report.
Sharma S; Narayan S; Kaur M
Indian J Pathol Microbiol; 2001 Apr; 44(2):157-8. PubMed ID: 11883136
[TBL] [Abstract][Full Text] [Related]
29. Acute lymphoblastic leukemia in a patient with chronic cyanoacrylate exposure.
Layden BT; Joseph M; Tallman MS; Platanias LC
Acta Haematol; 2007; 118(4):242-3. PubMed ID: 18087146
[TBL] [Abstract][Full Text] [Related]
30. Treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: a report from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan.
Matsuzaki A; Ishii E; Okamura J; Eguchi H; Yoshida N; Yanai F; Inoue T; Miyake K; Ishihara T; Tsuboi C
Med Pediatr Oncol; 1996 Jan; 26(1):10-9. PubMed ID: 7494507
[TBL] [Abstract][Full Text] [Related]
31. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
[TBL] [Abstract][Full Text] [Related]
32. Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: a Children's Cancer Group Study.
Heath JA; Steinherz PG; Altman A; Sather H; Jhanwar S; Halpern S; Pieters R; Shah N; Steinherz L; Tannous R; Terry W; Trigg ME;
J Clin Oncol; 2003 Apr; 21(8):1612-7. PubMed ID: 12697887
[TBL] [Abstract][Full Text] [Related]
33. Management of Ontario children with acute lymphoblastic leukemia by the Dana-Farber Cancer Institute protocols.
Desai SJ; Barr RD; Andrew M; deVeber LL; Pai MK
CMAJ; 1989 Oct; 141(7):693-7. PubMed ID: 2790605
[TBL] [Abstract][Full Text] [Related]
34. Molecular and clinical prognostic factors in BFM-treated childhood acute lymphoblastic leukemia patients: a single institution series.
Ruano D; Diaz MA; Tutor O; Garcia-Sanchez F; Martinez P; Madero L
Haematologica; 2000 Aug; 85(8):877-8. PubMed ID: 10942942
[No Abstract] [Full Text] [Related]
35. Plasma protein fractions and alpha 1-acidglycoprotein as tumor markers in acute lymphoblastic leukemia.
Abdalla A; Badrawy F; Khalifa A; Hamza R
Chemioterapia; 1987 Jun; 6(2 Suppl):743-4. PubMed ID: 3509537
[No Abstract] [Full Text] [Related]
36. Regeneration pattern of precursor-B-cells in bone marrow of acute lymphoblastic leukemia patients depends on the type of preceding chemotherapy.
van Lochem EG; Wiegers YM; van den Beemd R; Hählen K; van Dongen JJ; Hooijkaas H
Leukemia; 2000 Apr; 14(4):688-95. PubMed ID: 10764156
[TBL] [Abstract][Full Text] [Related]
37. Granular acute lymphoblastic leukemia.
Stein P; Peiper S; Butler D; Melvin S; Williams D; Stass S
Am J Clin Pathol; 1983 Apr; 79(4):426-30. PubMed ID: 6573125
[TBL] [Abstract][Full Text] [Related]
38. Acute lymphoblastic leukemia with azurophilic granules that contain ultrastructural myeloperoxidase activity.
Tauchi T; Ohyashiki K; Ohyashiki JH; Saito M; Nakazawa S; Enomoto Y; Hosoda Y; Toyama K
Am J Hematol; 1991 Apr; 36(4):288-90. PubMed ID: 1707229
[TBL] [Abstract][Full Text] [Related]
39. Blasts with abundant cytoplasmic granules: acute myeloid leukemia or granular acute lymphoblastic leukemia?
Xu J; Li S
Blood; 2017 Jan; 129(4):537. PubMed ID: 28126958
[No Abstract] [Full Text] [Related]
40. Enzyme histochemical, immuno histochemical and electron microscopic studies of two cases of leukemic malignant histiocytosis.
Hirose Y; Takiguchi T; Konda S; Konishi F; Sanada A; Nakagawa T
Int J Hematol; 1991 Apr; 54(2):125-35. PubMed ID: 1747445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
